• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 PET-CT 检查的预处理代谢肿瘤体积预测根治性手术治疗食管鳞癌患者的生存情况。

Use of pretreatment metabolic tumor volumes on PET-CT to predict the survival of patients with squamous cell carcinoma of esophagus treated by curative surgery.

机构信息

Department of Oncology, Jen-Ai Hospital-Ta Li, Taichung, Taiwan, ROC.

出版信息

Anticancer Res. 2012 Sep;32(9):4163-8.

PMID:22993379
Abstract

AIM

To investigate the prognostic role of the pretreatment metabolic tumor volume (MTV) as determined by Positron emission tomography--computed tomography (PET-CT) in patients with esophageal cancer undergoing curative surgery.

PATIENTS AND METHODS

We retrospectively reviewed the data of 26 patients with squamous cell carcinoma of the esophagus, who underwent 18F-Fluorodeoxyglucose PET-CT before surgery. MTVs were defined as the volumes with FDG uptake above a standardized uptake value (SUV) of 2.5 (MTV2.5), or a fixed threshold of 20% (MTV20%) of the maximum intratumoral activity. Overall survival (OS) and disease-free survival (DFS) were examined by the Kaplan-Meier method and the log-rank test.

RESULTS

In a median follow-up of 15 months, 13 patients had died. The mean MTV2.5 was 18.9 ± 15.4 ml (median, 16.0), whereas the mean MTV20% was 21.7 ± 15.0 ml (median, 19.1). Patients who had tumors of an MTV2.5 >16.0 ml had an inferior one-year OS compared with patients with a lower MTV2.5 (70% vs. 84%, p=0.018). Similarly, patients with an MTV20% >19.1 ml had poorer outcomes compared with patients who had small tumors, with one-year OS of 69% and 85%, respectively (p=0.016). No statistical significance was found in DFS for both MTV approaches. The SUVp-max had no impact on the OS and the DFS when using a median value of 8.3.

CONCLUSION

Pretreatment MTV is a novel marker for OS of patients with esophageal cancer treated with curative surgery. For those with higher MTVs, more aggressive adjuvant treatments should be considered.

摘要

目的

探讨正电子发射断层扫描-计算机断层扫描(PET-CT)测定的治疗前代谢肿瘤体积(MTV)在接受根治性手术的食管癌患者中的预后作用。

患者与方法

我们回顾性分析了 26 例接受 18F-氟脱氧葡萄糖 PET-CT 检查的食管鳞状细胞癌患者的数据。MTV 定义为 FDG 摄取量高于标准摄取值(SUV)2.5(MTV2.5)或最大肿瘤内活性的 20%(MTV20%)的体积。采用 Kaplan-Meier 法和对数秩检验检查总生存率(OS)和无病生存率(DFS)。

结果

在 15 个月的中位随访中,13 例患者死亡。MTV2.5 的平均值为 18.9 ± 15.4 ml(中位数为 16.0),而 MTV20% 的平均值为 21.7 ± 15.0 ml(中位数为 19.1)。MTV2.5>16.0 ml 的患者 1 年 OS 低于 MTV2.5 较低的患者(70%比 84%,p=0.018)。同样,MTV20%>19.1 ml 的患者与肿瘤较小的患者相比,预后较差,1 年 OS 分别为 69%和 85%(p=0.016)。两种 MTV 方法的 DFS 均无统计学意义。当 SUVp-max 使用 8.3 的中位数时,对 OS 和 DFS 没有影响。

结论

治疗前 MTV 是接受根治性手术治疗的食管癌患者 OS 的新型标志物。对于 MTV 较高的患者,应考虑更积极的辅助治疗。

相似文献

1
Use of pretreatment metabolic tumor volumes on PET-CT to predict the survival of patients with squamous cell carcinoma of esophagus treated by curative surgery.使用 PET-CT 检查的预处理代谢肿瘤体积预测根治性手术治疗食管鳞癌患者的生存情况。
Anticancer Res. 2012 Sep;32(9):4163-8.
2
Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy.治疗前代谢肿瘤体积预测接受确定性放化疗的不可切除局部晚期食管鳞状细胞癌的短期预后。
Nucl Med Commun. 2014 Mar;35(3):291-7. doi: 10.1097/MNM.0000000000000046.
3
Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.18F-氟代脱氧葡萄糖正电子发射断层扫描测量代谢肿瘤体积对食管癌患者的预后价值。
Ann Surg Oncol. 2010 Jan;17(1):115-22. doi: 10.1245/s10434-009-0719-7. Epub 2009 Oct 14.
4
Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.术前 PET-CT 代谢肿瘤体积对预测 I 期非小细胞肺癌患者无病生存的预后价值。
Anticancer Res. 2012 Nov;32(11):5087-91.
5
Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.头颈部癌症预处理 FDG-PET SUV 参数分析:肿瘤 SUVmean 具有更高的预后价值。
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):548-53. doi: 10.1016/j.ijrobp.2010.11.050. Epub 2011 Jan 27.
6
Clinical significance of pretreatment metabolic tumor volume and total lesion glycolysis in hypopharyngeal squamous cell carcinomas.下咽鳞状细胞癌治疗前代谢肿瘤体积和总病变糖酵解的临床意义
J Surg Oncol. 2014 Dec;110(7):869-75. doi: 10.1002/jso.23729. Epub 2014 Aug 2.
7
Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.采用 FDG PET/CT 测量的容积参数在接受立体定向体部放射治疗的 I 期 NSCLC 患者中的应用:预后价值。
Radiology. 2014 Jan;270(1):275-81. doi: 10.1148/radiol.13130652. Epub 2013 Oct 28.
8
Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.放化疗后正电子发射断层扫描预测食管癌患者的病理反应和生存。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):471-7. doi: 10.1016/j.ijrobp.2011.12.029. Epub 2012 Feb 28.
9
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.(18)F-FDG PET 代谢肿瘤负荷对非小细胞肺癌手术患者的预后价值。
Acad Radiol. 2013 Jan;20(1):32-40. doi: 10.1016/j.acra.2012.07.002. Epub 2012 Sep 19.
10
18F-FDG PET in patients with esophageal squamous cell carcinoma undergoing curative surgery: prognostic implications.18F-氟代脱氧葡萄糖正电子发射断层扫描在接受根治性手术的食管鳞状细胞癌患者中的应用:预后意义
J Nucl Med. 2004 Nov;45(11):1843-50.

引用本文的文献

1
PET-Assessed Metabolic Tumor Volume Across the Spectrum of Solid-Organ Malignancies: A Review of the Literature.实体器官恶性肿瘤全谱系中PET评估的代谢肿瘤体积:文献综述
Biomedicines. 2025 Jan 7;13(1):123. doi: 10.3390/biomedicines13010123.
2
The prognostic value of pretreatment [F]FDG PET/CT parameters in esophageal cancer: a meta-analysis.食管癌治疗前[F]FDG PET/CT参数的预后价值:一项荟萃分析。
Eur Radiol. 2025 Jun;35(6):3396-3408. doi: 10.1007/s00330-024-11207-3. Epub 2024 Nov 21.
3
The Prognostic Value of Sequential F-FDG PET/CT Metabolic Parameters in Outcomes of Upper-Third Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy.
序贯F-FDG PET/CT代谢参数对接受根治性放化疗的食管上段鳞状细胞癌患者预后的价值
World J Nucl Med. 2023 Sep 13;22(3):226-233. doi: 10.1055/s-0043-1774417. eCollection 2023 Sep.
4
The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.全瘤代谢体积对于预测胸段食管鳞癌术后复发的价值。
BMC Cancer. 2022 Nov 15;22(1):1176. doi: 10.1186/s12885-022-10281-4.
5
A Nutrition-Related Factor-Based Risk Stratification for Exploring the Clinical Benefits in the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: A Retrospective Cohort Study.一项基于营养相关因素的风险分层研究,旨在探索接受根治性放化疗的局部晚期食管鳞状细胞癌患者治疗中的临床获益:一项回顾性队列研究
Front Nutr. 2022 Aug 4;9:896847. doi: 10.3389/fnut.2022.896847. eCollection 2022.
6
Prognostic value of pre-treatment maximum standardized uptake value and CRP in radiotherapy of esophageal cancer.治疗前最大标准化摄取值和CRP在食管癌放疗中的预后价值
Mol Clin Oncol. 2021 Jul;15(1):146. doi: 10.3892/mco.2021.2308. Epub 2021 May 25.
7
Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model.作为一种源自术前FDG PET/CT的生物标志物,口腔鳞状细胞癌中的总病变糖酵解在新开发的多变量预测模型中优于既定的预后因素。
Oncotarget. 2021 Jan 5;12(1):37-48. doi: 10.18632/oncotarget.27857.
8
Metabolic parameters of sequential 18F-FDG PET/CT predict overall survival of esophageal cancer patients treated with (chemo-) radiation.连续 18F-FDG PET/CT 的代谢参数可预测接受(放)化疗的食管癌患者的总生存。
Radiat Oncol. 2019 Feb 19;14(1):35. doi: 10.1186/s13014-019-1236-x.
9
Value of sequential 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in prediction of the overall survival of esophageal cancer patients treated with chemoradiotherapy.序贯18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG PET/CT)在预测接受放化疗的食管癌患者总生存中的价值
Int J Clin Exp Med. 2015 Jul 15;8(7):10947-55. eCollection 2015.
10
Radiobiological Modeling Based on F-Fluorodeoxyglucose Positron Emission Tomography Data for Esophageal Cancer.基于氟脱氧葡萄糖正电子发射断层扫描数据的食管癌放射生物学建模
J Nucl Med Radiat Ther. 2014;5. doi: 10.4172/2155-9619.1000190.